Streetbeat News

Price Targets

CRM

Salesforce, Inc (NYSE:CRM) announced a price increase for many Clouds effective August 2023, marking its first price hike in seven years. The average list price increase is about 9% for the impacted products. Analysts from BMO Capital, Mizuho, Needham, and B of A Securities maintain Salesforce with an Outperform or Buy rating, raising the price targets. The price increase is expected to support growth in FY25 and provide margin leverage.

Portfolio Pulse from Anusuya Lahiri

July 12, 2023 | 6:21 pm

TMUS

A significant amount of unusual options activity has been observed for T-Mobile US (NASDAQ:TMUS), with a bullish stance taken by a majority of investors. Of the 36 strange trades detected, 52% were bullish and 47% were bearish. The total amount for puts was $727,270 and for calls was $931,075. Whales have been targeting a price range from $60.0 to $170.0 for T-Mobile US over the last 3 months. Morgan Stanley has maintained their Overweight rating on T-Mobile US, with a price target of $178.

Portfolio Pulse from Benzinga Insights

July 12, 2023 | 6:19 pm

INST

Needham & Co. analyst Ryan MacDonald initiated coverage on Instructure Holdings Inc (NYSE:INST) with a Buy rating and a price target of $32. MacDonald expects INST to benefit from its market-leading position in the North American higher ed LMS market and K-12 and 14-month federal funding and international growth. The analyst projects 10%+ growth and an approximate 30% FCF margin for INST in the next several years. INST shares are trading higher by 3.11% at $27.56.

Portfolio Pulse from Lekha Gupta

July 12, 2023 | 6:15 pm

RXST

Needham analyst David Saxon has reiterated a Buy rating on RxSight, Inc. (NASDAQ:RXST), raising the price target to $34 from $27. The analyst expects an upside to utilization and margins when the company reports 2Q results. Saxon also sees RxSight as an attractive acquisition target and believes it could sell for >10x forward EV/sales multiple, implying a share price of $45+.

Portfolio Pulse from Nabaparna Bhattacharya

July 12, 2023 | 6:07 pm

AMGN

In the last quarter, Amgen (NASDAQ:AMGN) received mixed analyst ratings with 1 bullish, 4 somewhat bullish, 1 indifferent, and 3 somewhat bearish. Over the past 3 months, 9 analysts have offered 12-month price targets for Amgen, with an average price target of $248.22, a 1.11% decrease from the previous average price target of $251.00.

Portfolio Pulse from Benzinga Insights

July 12, 2023 | 6:01 pm

EVR

Evercore's stock price is trading higher following Morgan Stanley's decision to raise its price target from $128 to $153.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 5:38 pm

LAZ

Lazard's stock has been upgraded from Equal-Weight to Overweight by Morgan Stanley, which also raised its price target from $36 to $43. This has resulted in Lazard shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 5:37 pm

UGRO

Small Cap Consumer Research analyst Eric Beder has reiterated a 'Buy' rating on Urban-gro (NASDAQ:UGRO) and maintained an $8 price target.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 5:35 pm

RGS

Small Cap Consumer Research analyst Eric Beder has reiterated a 'Buy' rating on Regis (NYSE:RGS) and maintained a $2 price target.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 5:34 pm

BMEA

EF Hutton analyst Tony Butler has reiterated a 'Buy' rating on Biomea Fusion (NASDAQ:BMEA) and maintained a price target of $43.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 5:33 pm